Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study will examine unmet exercise needs among patients with metastatic breast cancer (MBC) at UNC and assess whether participation in Get Real and Heel (GRH) can increase physical activity. The proposed research aims to improve multiple domains of well-being, quality of life, physical function, social support and reduce social isolation through a community based exercise intervention. By leveraging underutilized University of North Carolina Chapel Hill (UNC) resources, this work seeks to reduce barriers to accessibility, awareness, and appropriateness of exercise programming for this underserved population. Findings will help close the gap between patients' exercise needs, interest, and participation, with potential benefits for symptoms, functioning, and quality of life.
Sponsor: UNC Lineberger Comprehensive Cancer Center
You may qualify if…
- ✓ Written informed consent obtained to participate in the study and HIPAA authorization for release of personal health information.
- ✓ Subjects are willing and able to comply with study procedures based on the judgement of the investigator or protocol designee.
- ✓ Age \> 18 years at the time of consent.
- ✓ Diagnosis of metastatic breast cancer within two years of consent date
- ✓ Receives medical clearance from clinical team for moderate intensity exercise programming
- ✓ Indicates intent to receive ongoing cancer care at the enrolling institution
- ✓ English Speaking - program and measures are in English and not practicably translatable for a study this size.
You may not qualify if…
- ✕ Currently on hospice.
- ✕ Bed-bound status or other contraindication to exercise
- ✕ Participation in GRH since their diagnosis with MBC
Where it's recruiting
Chapel Hill
Source: ClinicalTrials.gov · NCT07313306 · last updated 2026-01-20